Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2–21 years …
Children and adolescents form a large proportion of societies and play an important role in
the transmission of COVID-19. On the other hand, their education, mental and physical …
the transmission of COVID-19. On the other hand, their education, mental and physical …
Liver injury, SARS‐COV‐2 infection and COVID‐19: What physicians should really know?
A Licata, MG Minissale, M Distefano, G Montalto - GastroHep, 2021 - Wiley Online Library
Abstract Background & Aims Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐
2) is responsible for coronavirus disease 2019 (COVID‐19), which in males, especially in …
2) is responsible for coronavirus disease 2019 (COVID‐19), which in males, especially in …
Pediatric and adolescent COVID‐19 vaccination side effects: A retrospective cohort study of the Iranian teenage group in 2021
N Tavakoli, N Nafissi, S Shokri… - Journal of medical …, 2022 - Wiley Online Library
To determine the safety and efficacy profile of teenager COVID‐19 vaccination. In this
retrospective cohort study, contact numbers of parents of teenagers under 18 years of age …
retrospective cohort study, contact numbers of parents of teenagers under 18 years of age …
Remdesivir use and risks of acute kidney injury and acute liver injury among patients hospitalised with COVID‐19: a self‐controlled case series study
Summary Background and Aim To investigate and quantify the risks of AKI and ALI
associated with remdesivir use, given the underlying diseases of SARS‐CoV‐2 infection …
associated with remdesivir use, given the underlying diseases of SARS‐CoV‐2 infection …
Factors predicting readmission in patients with COVID-19
M Nematshahi, D Soroosh, M Neamatshahi… - BMC research …, 2021 - Springer
Objective COVID-19 has been introduced by the World Health Organization as a health
emergency worldwide. Up to 9% of the patients with COVID-19 may be readmitted by 2 …
emergency worldwide. Up to 9% of the patients with COVID-19 may be readmitted by 2 …
[HTML][HTML] The effect of influenza vaccine on severity of COVID-19 infection: An original study from Iran
S Kalantari, A Sadeghzadeh-Bazargan… - Medical Journal of the …, 2021 - ncbi.nlm.nih.gov
Background: The COVID-19 infection is a novel virus that mainly targets the respiratory
system via specific receptors without any coronavirus-targeted therapies. Many efforts have …
system via specific receptors without any coronavirus-targeted therapies. Many efforts have …
Evaluation of epidemiology, clinical features, prognosis, diagnosis and treatment outcomes of patients with COVID‐19 in West Azerbaijan Province
N Gharebaghi, S Farshid, B Boroofeh… - … Journal of Clinical …, 2021 - Wiley Online Library
Background COVID‐19 is considered a widespread concern in global public health.
Diagnoses of COVID‐19 in some cases are necessary because of severe prognosis. In this …
Diagnoses of COVID‐19 in some cases are necessary because of severe prognosis. In this …
COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?
A Michalak, T Lach, K Szczygieł… - International Journal of …, 2024 - mdpi.com
The pandemic period due to coronavirus disease 2019 (COVID-19) revolutionized all
possible areas of global health. Significant consequences were also related to diverse …
possible areas of global health. Significant consequences were also related to diverse …
Repositioning antiviral drugs as a rapid and cost-effective approach to discover treatment against SARS-CoV-2 infection
The emergence of a novel, virulent, and pandemic strain of coronavirus termed Severe
Acute Respiratory Coronavirus 2 (SARS-CoV-2), the COVID-19 causative agent, challenged …
Acute Respiratory Coronavirus 2 (SARS-CoV-2), the COVID-19 causative agent, challenged …
Evaluation of the efficacy and safety of oral N‐acetylcysteine in patients with COVID‐19 receiving the routine antiviral and hydroxychloroquine protocol: A randomized …
Background The current absence of gold‐standard or all‐aspect favorable therapies for
COVID‐19 renders a focus on multipotential drugs proposed to prevent or treat this infection …
COVID‐19 renders a focus on multipotential drugs proposed to prevent or treat this infection …